Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Description of key information

In an oral acute toxicity study, the LD50 for malonic acid in male albino rats was 3250 mg/kg bw and for female albino rats 2750 mg/kg bw.

Key value for chemical safety assessment

Acute toxicity: via oral route

Link to relevant study records
Reference
Endpoint:
acute toxicity: oral
Type of information:
experimental study
Adequacy of study:
key study
Study period:
1976
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
comparable to guideline study with acceptable restrictions
Justification for type of information:
Study predates introduction of GLP and OECD guidelines, but follows acceptable scientific methods.
Qualifier:
equivalent or similar to guideline
Guideline:
OECD Guideline 401 (Acute Oral Toxicity)
GLP compliance:
no
Remarks:
Study carried out before introduction of GLP
Test type:
standard acute method
Limit test:
no
Species:
rat
Strain:
not specified
Sex:
male/female
Details on test animals or test system and environmental conditions:
Fasted albino rats weighing 200-300 g
Route of administration:
oral: gavage
Vehicle:
water
Details on oral exposure:
The product under test was placed in a glass syringe and introduced through the esophagus into the stomach with a stainless steel catheter.
Doses:
6 dose groups (males & females) + control group (males & females) with dosages of:- 1 000 mg/kg - 2 000 mg/kg- 2 500 mg/kg- 3 200 mg/kg- 4 000 mg/kg- 8 000 mg/kg
No. of animals per sex per dose:
5 per sex per dose5 per sex per control group
Control animals:
yes
Details on study design:
A group of approximately 70 albino male and female rats, fasted for twenty-four hours were employed to establish an LD50 range for each product under test.Young adult rats which had not been used for previous test purposes were assigned to various dose levels at random. Both sexes were equally distributed.The product under test was placed in a glass syringe and introduced through the esophagus into the stomach with a stainless steel catheter.Animals on the same dosage level were then placed in a common cage with free access to food and water. The animals were observed daily for atwo week period. No postmortem, or histopathology examinations were performed in this particular study
Statistics:
No data available
Preliminary study:
No preliminary study performed.
Key result
Sex:
male
Dose descriptor:
LD50
Effect level:
3 250 mg/kg bw
Based on:
test mat.
95% CL:
> 2 630 - < 4 000
Sex:
male
Dose descriptor:
LD0
Effect level:
2 000 mg/kg bw
Based on:
test mat.
Sex:
male
Dose descriptor:
LD100
Effect level:
8 000 mg/kg bw
Based on:
test mat.
Key result
Sex:
female
Dose descriptor:
LD50
Effect level:
2 750 mg/kg bw
Based on:
test mat.
95% CL:
> 2 280 - < 3 390
Sex:
female
Dose descriptor:
LD0
Effect level:
1 000 mg/kg bw
Based on:
test mat.
Sex:
female
Dose descriptor:
LD100
Effect level:
4 000 mg/kg bw
Mortality:
No mortality was observed at dose concentrations of 4000 mg/kg in males. Animals were found dead at 8000 mg/kg on day 4 and above (>8000 -32000 mg/kg) in male rats.No mortality was observed at dose concentrations of 4000 - 10000 mg/kg in females. Animals were found dead at 12500 mg/kg and above (>12500 -32000 mg/kg) in female rats.Details are given in the table below.
Clinical signs:
other: Male rats: unkempt coats were noted for 36-48 hours at 4000 mg/kg. At levels of 8000 mg/kg, 10000 mg/kg and 12500 mg/kg, lethargy was accompanied with spasmodic movements, nasal hemorrhage and unkempt coats. Survivors appeared normal by the ninth day.The
Gross pathology:
No Postmortem, or histopathology examinations were performed in this particular study.
Other findings:
No other findings

Mortality:

Dose Level (mg/kg)

No. of deaths (males)

Number of deaths (females)

1000

0

0

2000

0

1 (at day 2)

2500

1 (at day 1)

2 (at day 1)

3200

2 (at day 1)

3 (at day 1)

4000

4 (3 at day 1; 1 at day 2)

5 (at day 1)

8000

5 (at day 1)

5 (at day 1)

Interpretation of results:
Category 5 based on GHS criteria
Conclusions:
The LD50 for malonic acid in male albino rats is 3250 mg/kg bw and for female albino rats 2750 mg/kg bw in the acute toxicity study.
Executive summary:

In an oral acute toxicity study, the LD50 for malonic acid in male albino rats was 3250 mg/kg bw and for female albino rats 2750 mg/kg bw.

Endpoint conclusion
Endpoint conclusion:
adverse effect observed
Dose descriptor:
LD50
Value:
2 750 mg/kg bw

Acute toxicity: via inhalation route

Endpoint conclusion
Endpoint conclusion:
no study available

Acute toxicity: via dermal route

Endpoint conclusion
Endpoint conclusion:
no study available

Additional information

Justification for classification or non-classification